Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
neomycin + hydrokortison 0,5 %/1,5 %, örondroppar |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
Hydrocortisone acetate 15 mg/g and neomycin sulfate 5 mg/g ear or eye ointment |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortisonacetat 15 milligram/milliliter och neomycinsulfat 5 milligram/milliliter, öron- eller ögondroppar, lösning |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
bacitracinzink 400 enheter + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
dexametason 0,1 % vikt per volym + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, salva |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
dexametason 0,1 % vikt/volym + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, suspension |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
dexametason 1 mg + neomycinsulfat 3,5 mg, salva |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
dexametasonnatriumfosfat 1 mg + neomycinsulfat 3,5 mg, lösning |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
gramicidin 0,025 mg + neomycinsulfat 1,75 mg + polymyxin B-sulfat 10 000 enheter, lösning |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg, suspension |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/10 000 enheter, lösning |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortison 10 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10 000 enheter, suspension |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortison + neomycinsulfat + polymyxin B-sulfat 10 mg/7,5 mg/10 000 enheter, suspension |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortison 10 mg + neomycinsulfat 7,5 mg + polymyxin B-sulfat 1 000 enheter, lösning |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
hydrokortisonacetat 5 mg + neomysin 3,5 mg + polymyxin B-sulfat 10 000 IE, kräm |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
neomycinsulfat 0,35 % + polymyxin B-sulfat 10 000 E + prednisolonacetat 0,5 % vikt per volym, suspension |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|
Product containing fluocinolone and neomycin (medicinal product) |
Is a |
False |
Compound neomycin preparations |
Inferred relationship |
Some |
|